Headline
The latest stories from AHA Today.
Receiving two doses of the Pfizer or Moderna COVID-19 vaccine during pregnancy might help prevent your infant from being hospitalized for COVID-19 in the first six months after birth, according a study released today by the Centers for Disease Control and Prevention.
The Senate voted 50-46 to confirm as Food and Drug Administration commissioner Robert Califf, M.D., a professor at the Duke University School of Medicine and clinical researcher who briefly led the FDA during the Obama Administration.
The AHA released its 2022 Advocacy Agenda, a forward-looking document designed to positively influence the public policy environment for patients, communities and the health care field.
In a statement submitted to the Senate Finance Committee for a hearing on protecting children’s mental health, the AHA urged Congress to lift the caps on physician residency positions and increase scholarships, loan forgiveness and other financial supports to encourage health care providers to…
The Cybersecurity and Infrastructure Security Agency issued a rare “Shields Up” message recommending all U.S. organizations take immediate steps to enhance their ability to detect and protect against a cyber intrusion. The action follows a State Department advisory urging Americans to immediately…
During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released by the Centers for Disease…
The AHA and Musicians On Call are collaborating on a digital campaign to thank front-line caregivers around Valentine’s Day through digital promotions, social media and surprise virtual performances by celebrity artists.
The Centers for Disease Control and Prevention is accepting comments through April 11 on a draft updated clinical practice guideline for prescribing opioids for chronic pain.
Medicare yesterday expanded eligibility for lung cancer screening with low dose computed tomography by lowering the starting age for screening from 55 to 50 and reducing the tobacco smoking history from at least 30 packs per year to at least 20 packs per year.
The Food and Drug Administration today authorized emergency use of the monoclonal antibody bebtelovimab to treat COVID-19 in outpatients at risk of progressing to severe disease or hospitalization.